By leveraging Carbiosâ enzymatic depolymerization technology and Selenisâ expertise in polymerization, the companies aim to develop a premium, sustainable PETG material made from PET waste for the Cosmetic and Healthcare packaging sectors across Europe and the US. This partnership follows a two-year collaboration between the two companies and represents a significant advancement in the plastic recycling industry.
PETG is an indispensable packaging material in both the cosmetics and healthcare industries due to its exceptional clarity, durability, mechanical and chemical resistance. Carbiosâ enzymatic depolymerization solution breaks down all types of PET waste into PTA and MEG monomers, which are then transformed into PETG through Selenisâ polymerization processes.
Thanks to the purity of these monomers, PETG issued from biorecycling presents the same properties as virgin PETG, allowing for products packaged in thick, molded pots and lids to be protected and presented attractively. In the medical and pharmaceutical industries, PETG properties are also critical for guaranteeing top packaging performance, sterility, transparency and optical brightness, making it an ideal choice for complex medical device packaging, pharmaceuticals blisters, or any other packaging of diagnostic equipment. The materialâs value is therefore further underscored by combining a sustainable recycling solution whilst guaranteeing all needed properties, aligning with consumer sustainability demands and stringent regulatory requirements.
